WILMINGTON, Mass., April 3 /PRNewswire-FirstCall/ -- CardioTech International, Inc. today announced that it will be one of 13 companies participating in the exclusive Taglich Brothers Small Cap Equity Conference at 9:30 am. The event will be held at Le Parker Meridien, New York City where institutional investors will obtain insight into the small-cap sector through direct interaction with company management teams.
More information about the conference can be found at: http://www.taglich.com.
About CardioTech
CardioTech International, Inc. is a medical device company that develops, manufactures and sells advanced products to surgically treat cardiovascular disease. CardioTech is currently developing new products that address annual worldwide markets exceeding $1 billion. CardioPass is CardioTech’s proprietary, synthetic coronary artery bypass graft and CardioTech has partnered to develop a drug-eluting stent with CorNova.
CardioTech’s corporate headquarters are located in Wilmington, Massachusetts, with operations in California and Minnesota. CardioTech generates revenues from sales of advanced medical devices and disposables used during cardiopulmonary bypass procedures, as well as from contracted product design and development services. More information can be found about CardioTech at its website: http://www.cardiotech-inc.com.
For More Information Contact:
Eric G. Walters, Vice President and CFO
978 657 0075
CardioTech International, Inc.
CONTACT: Eric G. Walters, Vice President and CFO of CardioTechInternational, Inc., +1-978-657-0075
Web site: http://www.cardiotech-inc.com//
